Our study population including 222 Chinese NSCLC patients revealed that the high expression of ERβ was significantly correlated with poorer tumor differentiation and distant metastasis, which predict poor prognosis in the malignant tumor. The gene discussed is ESR2; the disease is non-small cell lung carcinoma.